We also assessed programmed cell death protein 1 (PD1) expression on T cells and programmed cell death ligand protein 1 (PD-L1) within the tumor to rule out tumor growth differences attributed to the immune function within the TME. This evidence concerns the gene CD274 and neoplasm.